<DOC>
	<DOCNO>NCT01723904</DOCNO>
	<brief_summary>This study investigate safety efficacy Rotigotine add-on therapy low dos Pramipexole Ropinirole patient advanced-stage Parkinson 's Disease ( PD ) insufficient response L-dopa low dos dopamine receptor agonist .</brief_summary>
	<brief_title>A Phase 3b , Open-Label , Safety Efficacy Study Rotigotine Add-On Therapy With Low Doses Pramipexole Ropinirole Patients With Advanced Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Subject male female , age ≥ 30 &lt; 80 year informed consent Subject idiopathic Parkinson 's Disease , 3 year duration , define cardinal sign , bradykinesia , presence least 1 follow : rest tremor , rigidity , impairment postural reflex , without know suspected cause Parkinsonism Subject motor fluctuation wear , dyskinesia Subject experience nocturias least 3 night within 7 day prior Baseline Subject take levodopa ( LDOPA , immediate and/or control release ) combination benserazide carbidopa stable dose LDOPA least 28 day prior Baseline ( Visit 2 ) Subject take nonergot dopamine agonist ( pramipexole ≤ 1.5 mg/day ropinirole ≤ 6.0 mg/day ) stable dose nonergot dopamine agonist least 28 day prior Baseline ( Visit 2 ) Subject receive therapy tolcapone budipine Subject receive therapy one follow drug either concurrently within 28 day prior Baseline ( Visit 2 ) : alphamethyl dopa , metoclopramide , reserpine , neuroleptic ( except specific atypical neuroleptic : olanzapine , ziprasidone , aripiprazole , clozapine , quetiapine ) , monoamine oxidase A ( MAOA ) inhibitor , methylphenidate , amphetamine Subject history symptomatic ( asymptomatic ) orthostatic hypotension within 6 month prior Baseline ( Visit 2 ) Subject know hypersensitivity component study medication , history significant skin hypersensitivity adhesive , know hypersensitivity transdermal medication , unresolved contact dermatitis Subject pregnant nursing , childbearing potential ( ie , ( ) surgically sterile , , ( ii ) use adequate birth control method [ include least one barrier method ] , ( iii ) sexually abstinent , ( iv ) least 2 year post menopausal ) Subject previous diagnosis narcolepsy , sleep apnea syndrome , restless legs syndrome , periodic limb movement disorder</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>Neupro</keyword>
</DOC>